Among the pharmacological drugs used in cardiac stress testing, regadenoson is a very effective vasodilator. Its chemical name, Regadenoson, may not be well known outside of expert circles, but its use in myocardial perfusion imaging (MPI) is critical.
Popular Search Topics
Myocardial perfusion imaging medications, Regadenoson MPI agent, Regadenoson 313348-27-5, a vasodilator for cardiac duress, and Regadenoson safety profile.
Other products in the same market
Adenosine, Dipyridamole, and Dobutamine are some of the drugs that compete with it on the market. While all of these drugs are used to improve myocardial perfusion imaging, their mechanisms of action and pharmacological profiles are rather different.
Benefits for Your Well-being
The most important advantage of regadenoson is the function it plays in improving the diagnostic clarity of MPI, in particular for patients who are unable to participate in physical exercise stress testing. Dilation of the coronary arteries and increased blood flow to the myocardium aid in coronary artery disease assessment.
The drug is well-known for its quick start of action and brief half-life, which provide temporary coronary vasodilation, a result that is intended for MPI testing.
Explanation of Product Mechanism
Regadenoson, being a selective A2A adenosine receptor agonist, exerts its effects with more specificity than non-selective medicines, lowering the risk of adverse events. It increases coronary blood flow by stimulating these receptors, thereby inducing coronary vasodilation.
Ensuring Safety and Addressing Potential Side Effects
Regadenoson is thought to be safe for use in the specified group when given according to the instructions. Headaches, nausea, dizziness, and chest pain are only some of the possible negative reactions.
Information on Dosage
During MPI, the standard dosage is a single, very quick intravenous injection of 0.4 mg. This is the recommended amount.
Patients with second- or third-degree AV block or sinus node dysfunction should not utilize regadenoson without an artificial pacemaker.
Regadenoson is a very advanced cardiac imaging instrument. Because of its specific action and acceptable safety profile, it is a beneficial agent in the evaluation of coronary artery disease. The application of the compound in clinical settings highlights the substantial advancements achieved in non-invasive cardiology diagnostics. For the sake of both patient well-being and correct diagnostic interpretation, it is important to exercise caution while administering this or any other pharmacological substance.
Exploring Regadenoson: Its Role and Mechanism in Non-Exercise Cardiac Stress Testing and Myocardial Perfusion Imaging
Regadenoson coronary vasodilator,
Pharmacologic stress testing agent,
Coronary artery disease diagnosis,
Selective A2A adenosine receptor agonist,
Hyperemia induction drugs,
Myocardial perfusion imaging with regadenoson,
Lexiscan for stress testing,
Adenosine receptor targeting medications,
Non-exercise cardiac assessment,
Regadenoson in myocardial perfusion.
Send your message to us
We are committed to serve the diverse needs of our customers in drug discovery, custom synthesis and specialty or performance chemicals.